// App-Quantinova.ai

WP313 2015 ASA : Risk of Rebleed with Resumption of Anticoagulation after Intracranial Hemorrhage

Researchers

Presenter

  • Errol Gordon

Principal Investigators

  • Jennifer A Frontera

Medical Centers

  • Cleveland Clinic Lerner Coll of Med, Cleveland, OH

  • Mount Sinai School of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Cardiac valvular dysplasia X-linked

  • Myocardial infarction

  • Deep vein thrombosis

  • Pulmonary embolism

  • Arrhythmia

  • Venous thrombosis

  • Hematoma

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved